Data from U.S. surgeons suggest novel drug for symptomatic VMA can increase likelihood of success through careful patient selection. » Read the analysis
|
In his latest column, Peter McDonnell, MD, chief medical editor of Ophthalmology Times, writes of a recent political scandal involving a doctor, and why full disclosure is a good thing. » Read Dr. McDonnell's editorial
|
Consideration of the economics of part-time practice can produce a win-win situation for practices and employees, said Robert E. Wiggins, MD, MHA. » Find out more
|
Switching treatment is not uncommon in medicine. In fact, a number of studies with patients who have rheumatoid arthritis or multiple sclerosis have found benefits from switching. Yet, just how effective is switching medications for patients with exudative AMD? » Find out here
|
|
|